The Tumor Genomics Market was USD 21.42 billion in 2020 and is expected to reach USD 56.54 billion in 2028 and register a revenue CAGR of 12% during the forecast period 2022-2028. There are multiple factors that drive the tumor genomics market such as rising government initiatives, increasing number of product approvals and launches, and rising incidence […]
